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OBJECTIVES: To assess preference and willingness-to-
pay (WTP) for the insulin mixture Humalog Mix25 rel-
ative to Humulin 30/70, from the perspective of patients
in ﬁve European countries. The relative value of indi-
vidual treatment attributes was also determined.
METHODS: A total of 290 patients with type 2 diabetes
were enrolled from 5 European countries. Of these, 235
were suitable for inclusion in the analysis. Their mean age
was 51.3 years and, on average, patients had had diabetes
for 11 years. A discrete-choice conjoint analysis was con-
ducted using face-to-face interviews. Treatment attributes
and levels were derived from published comparative clin-
ical trial data available at July 2001. The attributes used
were: timing of injections around meals; two-hour post-
prandial control; effect of prandial dosing; frequency of
nocturnal hypoglycaemia; and cost. RESULTS: 90%
(95% CI 86–93%) of patients would choose Humalog
Mix25 over Humulin 30/70, at the same cost. On
average, European subjects were willing to pay €111 
per month more for Humalog Mix25 (95% CI
€86.71–156.91). The primary driver was the reduced risk
of nocturnal hypoglycaemic events, contributing 49% of
WTP. The convenience of dosing immediately prior to the
meal contributed 37% and improved postprandial blood
glucose concentrations contributed 14% to the WTP.
Preference results were similar in all ﬁve countries,
although WTP and sensitivity to increasing cost varied
from country to country. The WTP values for individual
countries were: France €146.83; Germany €126.65; Italy
€56.98; Spain €150.06; United Kingdom €194.36. French
and UK patients were relatively insensitive to increasing
cost, while Italian patients were highly cost-sensitive.
CONCLUSIONS: Patients in all countries showed a clear
preference for Humalog Mix 25 over Humulin 30/70.
WTP ﬁgures for the individual countries can be compared
with the corresponding additional acquisition costs for
Humalog Mix25, relative to Humulin 30/70, to assess the
extent of welfare gain to the community.
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OBJECTIVES: There is increasing awareness that equity
weights should be used to recalculate the value of QALY
gains for different patients. It is unclear however how
these equity weights should be determined: on the basis
of health prospects (for instance “rule of rescue”), fair
innings, or on a combination of both, for instance an
equity concept that has been referred to as proportional
shortfall. To answer this question, we compared the
observed rank order of 10 conditions with the theoreti-
cal rank orders that were predicted by each equity
concept. METHODS: 60 respondents (students, re-
searchers, health policy makers) rank ordered 10 condi-
tions using the paired comparison technique. This
observed rank order was compared to the rank orders
expected on the basis of the equity concepts fair innings,
prospective health and proportional shortfall. To allow
for comparison of the conditions in terms of each equity
concept, we described the conditions in terms of age,
disease free period, duration of disease, quality of life, and
life years lost. RESULTS: The observed rank order of the
10 conditions was best predicted by the fair innings
concept (corr. = 0.908, p < 0.01). Proportional shortfall
was also well correlated with the observed rank order of
the conditions (corr. = 0.780, p < 0.01), but prospective
health was not statistically signiﬁcantly related. This is
remarkable, as it has often been suggested that the “rule
of rescue” is the most important determinant of the dis-
tribution of health care. CONCLUSIONS: Measurable
interpretations of equity make it possible to test the
importance of concepts of equity in the allocation of
health care. The fair innings argument and proportional
shortfall may provide a basis for determining equity
weights for recalculating the value of QALY gains for dif-
ferent patients. When put to a critical test, the prospec-
tive health argument is out weighted by arguments
resembling fair innings.
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